Effects of the Tangningtongluo formula as an alternative strategy for diabetics via upregulation of insulin receptor substrate-1.

Abstract

Tangningtongluo (TNTL), a traditional Chinese medicine, has been widely used in clinics for decades in southwest China. Its pharmacological properties and underlying molecular mechanisms remain unclear. The main goal of ethnopharmacology is to identify novel bioactive compounds derived from plants for use in indigenous medical practice. This knowledge can be used to develop novel pharmaceuticals. In the present study, hyperglycemic C57BL/KsJ‑db/db (db/db) mice were used to test the effect of TNTL on microvasculature of the retina and hypoglycemia. Metformin (Met) was selected as a positive control. 26‑week‑old mice were randomly assigned to receive either the anti‑diabetic agent Met [140 mg/kg body weight (BW)], 1.8, 0.9 or 0.45 g/kg BW TNTL, or a placebo. The fasting blood glucose, serum insulin and glycated hemoglobin levels were measured. Histopathologic examination of the pancreas was performed to confirm the hypoglycemic effect. Fluorescein angiography was applied to detect diabetes‑induced retinal angioma in the db/db mice. TNTL intake significantly decreased the fasting blood glucose level in a dose‑dependent manner. Additionally, TNTL intervention resulted in a significant decrease in the insulin resistance index. Notably, TNTL treatment markedly reduced the speed of retinal degeneration and mildly reversed microvascular caliber degeneration. Western blot analysis indicated that upregulation of phosphorylated insulin receptor substrate‑1 (p‑IRS‑1) by the administration of TNTL may be strongly involved in the improvement of insulin resistance. In conclusion, TNTL exerted a strong hypoglycemic effect and reversed retinal degeneration via upregulation of ISR‑1. The present findings provide important scientific evidence supporting TNTL as an effective alternative approach for the management of Type 2 diabetes mellitus.

• Authors: Long Cheng, Junmei Song, Geng Li, Yue Liu, Yuming Wang, Xiangbao Meng, Guibo Sun, Xiaobo Sun
• Journal: Molecular medicine reports (Mol Med Rep) Vol. 16 Issue 1 Pg. 703-709 (Jul 2017) ISSN: 1791-3004 [Electronic] Greece
• PMID: 28586073 (Publication Type: Journal Article)

Chemical References

• Biomarkers
• Blood Glucose
• Drugs, Chinese Herbal
• Glycated Hemoglobin A
• Insulin
• Insulin Receptor Substrate Proteins
• Lipids
• tangningtongluo

Topics

• Animals
• Biomarkers
• Blood Glucose
• Diabetes Mellitus, Type 2 (drug therapy, genetics, metabolism)
• Disease Models, Animal
• Drugs, Chinese Herbal (pharmacology)
• Female
• Gene Expression Regulation (drug effects)
• Glycated Hemoglobin (metabolism)
• Insulin (blood)
• Insulin Receptor Substrate Proteins (genetics, metabolism)
• Insulin Resistance
• Lipids (blood)
• Liver (drug effects, metabolism)
• Mice
• Muscles (drug effects, metabolism)
• Retinal Degeneration (diagnostic imaging, etiology, metabolism, pathology)